Age-related changes in the immune system and cognitive disorders in vascular dementia and Alzheimer’s disease

Nuvakhova M.B.; Rachin S.A.

doi:https://doi.org/10.17116/jnevro2020120081154

Close metadata

Recommended articles:

Cytokine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12

Curcumin-induced increased retinal fluorescence as a new method in the early diagnosis of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):19-25

Differential diagnosis of Alzheimer’s disease and vascular cognitive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35

A comprehensive study of Alzheimer’s disease biomarkers in plasma and cerebrospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53

Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60

Analysis of cognitive status in patients with different nosologies and clinical variants of very late manifesting schizophreniform psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):88-93

Novel prospects for early diagnosis of cognitive impairment using Eye-tracking technology. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):13-20

Cerebral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):15-24

Features of facial expressions in patients with cognitive impairment due to Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):104-109

Potential and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medicine. 2025;(7):94-99

Abstract:

The immune mechanisms of cognitive impairment are considered. Various causal relationships of the development of immune and neurodegenerative disorders, including vascular dementia (VD) and Alzheimer’s disease (AD), are analyzed. It has been shown that age-related adaptive restructuring of immunity leads to the fact that lymphocytic immunity as a whole begins to work in an intermediate metastable state. The dominant role of immune factors in the development of VD and AD is highlighted. It is concluded that the pathogenesis of neurodegenerative diseases is associated with a decrease in antibody activity. The number of cytokines in aging animals is significantly reduced which leads to a decrease in the level of the immune response of the cell.

Keywords:

cognitive disorders

vascular dementia

Alzheimer’s disease

antibody

immunity

Authors:

Nuvakhova M.B.

National Medical Research Center For Rehabilitation And Health Resort Studies

Rachin S.A.

Pavlov First Saint Petersburg State Medical University

Received:

04.11.2019

Accepted:

09.04.2020

Close metadata

References:

Hebert LE, Scherr PA, Beckett LA. Age specific incidence of Alzheimer’s disease in a community population. JAMA. 1995;273(17):1354-1359.
Rocca WA, Hofman A, Brayne C. Frequency and distribution of Alzheimer’s disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Annals of Neurology. 1991;30(3):381-390. https://doi.org/10.1002/ana.410300310
Ferri CP, Sousa R, Albanese E, Ribeiro WS, Honyashikil M. Alzheimer’s Disease International. World Alzheimer Report. 2009;93:23-30.
Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. Review. J Neurol Sci. 2007;257(1-2):80-87. https://doi.org/10.1016/j.jns.2007.01.045
Selkoe DJ. Defining molecular targets to prevent Alzheimer’s disease. Arch Neurol. 2005;62(2):192-195. https://doi.org/10.1001/archneur.62.2.192
Schenkein JG, Park S, Nahm MH. Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine. 2008;26(43):5521-5526. https://doi.org/10.1016/j.vaccine.2008.07.071
Huang YP, Gauthey L, Michel M, Loreto M, Paccaud M, Pechere JC, Michel JP. The Relationship Between Influenza Vaccine-Induced Specific Antibody Responses and Vaccine-Induced Nonspecific Autoantibody Responses in Healthy Older Women. J of Gerontology. 1992;47(2):50-55. https://doi.org/10.1093/geronj/47.2.M50
Kolibab K, Smithson SL, Rabquer B, Khuder S, Westerink MA. Immune Response to Pneumococcal Polysaccharides 4 and 14 in Elderly and Young Adults: Analysis of the Variable Heavy Chain Repertoire. Infect Immun. 2005;73(11):7465-7476. https://doi.org/10.1128/IAI.73.11.7465-7476.2005
Louveau A, Smirnov I, Keyes TJ. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337-341. https://doi.org/10.1038/nature14432
Wong PC, Savonenko A, Li T, Price DL. Neurobiology of Alzheimer’s Disease. In: Basic Neurochemistry, Eighth Edition: Principles of Molecular, Cellular, and Medical Neurobiology. Brady S, Siegel G, eds. Amsterdam, London, etc.: Academic Press; 2012.
Filiano AJ, Xu Y, Tustison NJ, Marsh RL. Unexpected role of interferon-γ in regulating neuronal connectivity and social behavior. Nature. 2016; 535(7612):425-429. https://doi.org/10.1038/nature18626
Sleegers K, Van Duijn CM. Alzheimer’s disease: genes, pathogenesis and risk prediction. Community Genet. 2001;4(4):197-203. https://doi.org/10.1159/000064193
Bohm C, Chen F, Sevalle J. Current and future implications of basic and translation-al research on amyloid-ß peptide production and removal pathways. Mol Cell Neurosci. 2015;66(Pt A):3-11. https://doi.org/10.1016/j.mcn.2015.02.016
Sims R, Williams J. Defining the genetic architecture of Alzheimer’s disease: where next. Neurodegenerative Diseases. 2016;16(1-2):6-11. https://doi.org/10.1159/000440841
Sims R, Van Der Lee SJ, Naj AC. Rare coding variants in PLCG2, ABI3 and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nature Genetics. 2017;49(9):1373-1384. https://doi.org/10.1038%2Fng.3916
Leonenko G, Shoai M, Bellou E. Genetic risk for Alzheimer’s disease is distinct from genetic risk for amyloid deposition. Annals of Neurology. 2019;86(3):427-435. https://doi.org/10.1002/ana.25530
Vom Berg J, Prokop S, Miller KR. Inhibition of IL-12/IL-23 signaling reduces Alzheimer’s disease — like pathology and cognitive decline. Nature Medicine. 2012;18(12):1812-1819. https://doi.org/10.1038/nm.2965
Kumar DV, Choi SH, Washicosky KJ. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Science Translational Medicine. 2016;8(340):1-16. https://doi.org/10.1126/scitranslmed.aaf1059
Soscia SJ, Kirby JE, Washicosky KJ. The Alzheimer’s Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide. PLoS One. 2010;5(3): e9505:1-10. https://doi.org/10.1371/journal.pone.0009505
Shi Q, Chowdhury S, Ma R. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Science Translational Medicine. 2017;9(392):eaaf6295. https://doi.org/10.1126/scitranslmed.aaf6295
Alzheimer’s Disease International. Dementia statistics. Accessed November 2016. https://www.alz.co.uk/research/statistics
Alzheimer’s Association Report. Alzheimer’s Disease Facts and Figures. Alzheimer’s & Dementia. 2016;12(4):459-509. https://doi.org/10.1016/j.jalz.2016.03.001
Scharre DW, Weichart E, Nielson D. Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer’s Disease. Journal of Alzheimer’s Disease. 2018;62(2):621-633. https://doi.org/10.3233/JAD-170082
Bu XL, Xiang Y, Jin WS. Blood-derived amyloid-β protein induces Alzheimer’s disease pathologies. Molecular Psychiatry. 2018;23(9):1948-1956. https://doi.org/10.1038/mp.2017.204
Jaunmuktane Z, Mead S, Ellis M. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature. 2015; 525(7568):247-250. https://doi.org/10.1038/nature15369
Readhead B, Haure-Mirande JV, Funk CC. Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. 2018;99(1):64-82. https://doi.org/10.1016/j.neuron.2018.05.023
Dominy SS, Lynch C, Ermini F. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Science Advances. 2019;5(1):1-21. https://doi.org/10.1126/sciadv.aau3333
Finlay BB, Hancock RE. Can innate immunity be enhanced to treat microbial infections? Nat Rev Micro. 2004;2(6):497-504. https://doi.org/10.1038/nrmicro908
Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Micro. 2005;3(3):238-250. https://doi.org/10.1038/nrmicro1098
Breukink E, de Kruijff B. Lipid II as a target for antibiotics. Nat Rev Drug Discov. 2006;5(4):321-323. https://doi.org/10.1038/nrd2004
Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL. Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. Journal of Experimental Medicine. 1999;190(7):1013-1024. https://doi.org/10.1084/jem.190.7.1013
Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci USA. 2003;100(25):15053-1505. https://doi.org/10.1073/pnas.2433717100
Kang JE, Lim MM, Bateman RJ. Amyloid — Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle. Science. 2009;326(5955):1005-1007. https://doi.org/10.1126/science.1180962
Nelson PT, Dickson DW, Trojanowski JQ. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503-1527. https://doi.org/10.1093/brain/awz099
Hasegawa M, Arai T, Nonaka T. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008;64(1):60-70. https://doi.org/10.1002/ana.21425
Amador-Ortiz C, Ahmed Z, Zehr C, Dickson DW. Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol. 2007;113(3):245-252. https://doi.org/10.1007/s00401-006-0183-4
Parfenov VA. Prevention of Alzheimer’s Disease. Neurology, Neuropsychiatry, Psychosomatics. 2011;3(3):8-13. (In Russ.) https://doi.org/10.14412/2074-2711-2011-159
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64-74. https://doi.org/10.1016/S1474-4422(05)70284-2
Wu KY, Hsiao IT, Chen CS. Increased brain amyloid deposition in patients with a lifetime history of major depression: evidence on positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41(4):714-722. https://doi.org/10.1007/s00259-013-2627-0
Tan ZS, Vasan RS. Thyroid function and Alzheimer’s disease. J Alzheimers Dis. 2009;16(3):503-507. https://doi.org/10.3233/JAD-2009-0991
Pardon MC, Rattray I. What do we know about the long-term consequences of stress on ageing and the progression of age-related neu-rodegenerative disorders? Neurosci Biobehav Rev. 2008;32(6):1103-1120. https://doi.org/10.1016/j.neubiorev.2008.03.005
Rachin AP, Nuvakhova MB, Tynterova AM, Rachin SA. Neuropeptide therapy of cognitive disorders in the setting of the chronic cerebral ischemia. Russian Medical Journal. 2019;4(II):87-90. (In Russ.)
Zhou J, Thompson DK. Microbial functional genomics. Wiley-Liss. 2004:590.
Ellis TN, Beaman BL. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology. 2004;112(1):2-12. https://doi.org/10.1111/j.1365-2567.2004.01849.x
Ron-Harel N, Notarangelo G, Ghergurovich JM. Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice. PNAS. 2018;115(52):13347-13352. https://doi.org/10.1073/pnas.1804149115
Li M, Yao D, Zeng X, Kasakovski D. Age related human T cell subset evolution and senescence. Immunity & Ageing. 2019;16(24):2-7. https://doi.org/10.1186/s12979-019-0165-8
Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint JP, Labalette M. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev. 2006; 127(3):274-281. https://doi.org/10.1016/j.mad.2005.11.001
Weng NP, Akbar AN, Goronzy J. CD28(–) T cells: their role in the age-associated decline of immune function. Trends Immunol. 2009;30(7):306-312. https://doi.org/10.1016/j.it.2009.03.013
Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2014;14(1):24-35. https://doi.org/10.1038/nri3567
Goronzy JJ, Fang FQ, Cavanagh MM. Naive T cell maintenance and function in human aging. J Immunol. 2015;194(9):4073-4080. https://doi.org/10.4049/jimmunol.1500046
Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an aging population. Immunology. 2007;120(4):435-446. https://doi.org/10.1111/j.1365-2567.2007.02555.x
Bektas A, Schurman SH, Sen R, Ferrucci L. Human T cell immunosenescence and inflammation in aging. J Leukoc Biol. 2017;102(4):977-988. https://doi.org/10.1189/jlb.3RI0716-335R
Vasson MP, Farges MC, Goncalves-Mendes N. Does aging affect the immune status? A comparative analysis in 300 healthy volunteers from France, Austria and Spain. Immun Ageing. 2013;10(1):38-41. https://doi.org/10.1186/1742-4933-10-38
Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev Journal. 1999;79(1):1-71. https://doi.org/10.1152/physrev.1999.79.1.1
Sergienko IV, Nozadze DN, Kaznacheeva EI. The influence of chemokines on the formation of atherosclerotic lesions due to the regulation of leukocyte function. Atherosclerosis and Dyslipidemia. 2012;3:37-47. (In Russ.)